Mipomersen Sodium is a synthetic antisense oligonucleotide used as an adjunct therapy for the treatment of homozygous familial hypercholesterolemia. By binding to the mRNA that encodes for apolipoprotein… Read more
Mipomersen Sodium is a synthetic antisense oligonucleotide used as an adjunct therapy for the treatment of homozygous familial hypercholesterolemia. By binding to the mRNA that encodes for apolipoprotein B-100, this drug inhibits the synthesis of apoB-containing lipoproteins, thereby reducing cholesterol levels. To support the rigorous analytical requirements of drug development, this category provides high-quality reference standards, including identified impurities, metabolites, and stable isotope labelled compounds. These materials are critical for laboratories performing precise impurity profiling and method validation, where distinguishing the active pharmaceutical ingredient from related synthesis-derived variants or degradation products is essential. Furthermore, stable isotope-labelled standards enable accurate quantification during bioanalytical studies, ensuring the sensitivity and specificity required for complex oligonucleotide analysis. Pharmaceutical laboratories utilize these tools to maintain consistent quality control and meet the stringent regulatory standards necessary for the characterization of oligonucleotide therapeutics.